These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 30213986)

  • 1. Increased carotid intima-media thickness in patients with radiographic axial spondyloarthritis compared to controls and associations with markers of inflammation.
    Law L; Lindqvist P; Liv P; Hellman U; Lejon K; Geijer M; Söderberg S; Forsblad-d'Elia H
    Clin Rheumatol; 2024 May; 43(5):1559-1570. PubMed ID: 38443604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients.
    Ferraz-Amaro I; Genre F; Blanco R; Calvo-Rio V; Corrales-Selaya C; Portilla V; Aurrecoechea E; Batanero R; Hernández-Hernández V; Quevedo-Abeledo JC; Rodríguez-Lozano C; López-Medina C; Ladehesa-Pineda L; Castañeda S; Vicente-Rabaneda EF; Fernández-Carballido C; Martínez Vidal MP; Castro Corredor D; Anino Fernández J; Peiteado D; Plasencia-Rodriguez C; Expósito R; Garcia Vivar ML; Galíndez-Agirregoikoa E; Vegas N; Urionagüena I; Montes-Perez E; Gonzalez-Gay MA; Rueda-Gotor J
    RMD Open; 2024 Jun; 10(2):. PubMed ID: 38942590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated type-17 cytokines are present in axial spondyloarthritis stool.
    Brough I; Thompson K; Latore C; Penkava F; Regan C; Pearson C; Shi H; Ridley A; Simone D; Lam L; Bullers S; Moussa C; Feeney R; ; Al-Mossawi MH; Powrie F; Young S; Huttenhower C; Bowness P
    Discov Immunol; 2024; 3(1):kyae005. PubMed ID: 38966778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calprotectin in spondyloarthritis and gut inflammation, is it clinically meaningful?
    Tung KK; Chen ST; Lee CH; Tung CF; Wei JC
    Int J Rheum Dis; 2023 Apr; 26(4):609-612. PubMed ID: 37002903
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis.
    Corrales A; Vegas-Revenga N; Atienza-Mateo B; Corrales-Selaya C; Prieto-Peña D; Rueda-Gotor J; Portilla V; Blanco R; Castañeda S; Ferraz-Amaro I; Llorca J; González-Gay MA
    Rheumatology (Oxford); 2021 Jun; 60(6):2801-2807. PubMed ID: 33249513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis.
    Genre F; Rueda-Gotor J; Remuzgo-Martínez S; Pulito-Cueto V; Corrales A; Mijares V; Lera-Gómez L; Portilla V; Expósito R; Mata C; Blanco R; Llorca J; Hernández-Hernández V; Vicente E; Fernández-Carballido C; Martínez-Vidal MP; Castro-Corredor D; Anino-Fernández J; Rodríguez-Lozano C; Gualillo O; Quevedo-Abeledo JC; Castañeda S; Ferraz-Amaro I; López-Mejías R; González-Gay MÁ
    Sci Rep; 2020 Jun; 10(1):9636. PubMed ID: 32541676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis.
    Diaconu AD; Ceasovschih A; Șorodoc V; Pomîrleanu C; Lionte C; Șorodoc L; Ancuța C
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction and increased carotid intima-media thickness in patients with spondyloarthritis without traditional cardiovascular risk factors.
    Ben Tekaya A; Boukriba S; Fendri A; Rouached L; Saidane O; Bouden S; Tekaya R; Ben Salem K; Mahmoud I; Habiba M; Abdelmoula L
    RMD Open; 2022 Jul; 8(2):. PubMed ID: 35793876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients.
    Bayrakci N; Ozkan G; Kara SP; Yilmaz A; Guzel S
    Int J Hypertens; 2022; 2022():6912502. PubMed ID: 35096423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study.
    Rueda-Gotor J; López-Mejías R; Remuzgo-Martínez S; Pulito-Cueto V; Corrales A; Lera-Gómez L; Portilla V; González-Mazón Í; Blanco R; Expósito R; Mata C; Llorca J; Hernández-Hernández V; Rodríguez-Lozano C; Barbarroja N; Castro RO; Vicente E; Fernández-Carballido C; Martínez-Vidal MP; Castro-Corredor D; Anino-Fernández J; Peiteado D; Plasencia-Rodríguez C; Galíndez-Agirregoikoa E; García-Vivar ML; Gualillo O; Quevedo-Abeledo JC; Castañeda S; Ferraz-Amaro I; González-Gay MÁ; Genre F
    Arthritis Res Ther; 2021 Apr; 23(1):111. PubMed ID: 33849644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for outcomes of spondyloarthritis.
    Romand X; Douillard C; Baillet A
    Joint Bone Spine; 2017 Jul; 84(4):385-387. PubMed ID: 28238884
    [No Abstract]   [Full Text] [Related]  

  • 13. Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis.
    Ammirati E; Moroni F; Norata GD; Magnoni M; Camici PG
    Mediators Inflamm; 2015; 2015():718329. PubMed ID: 25960621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of circulating calprotectin with lipid profile in axial spondyloarthritis.
    Genre F; Rueda-Gotor J; Remuzgo-Martínez S; Corrales A; Mijares V; Expósito R; Mata C; Portilla V; Blanco R; Hernández JL; Llorca J; Gualillo O; López-Mejías R; González-Gay MA
    Sci Rep; 2018 Sep; 8(1):13728. PubMed ID: 30213986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity.
    de Armas-Rillo L; Quevedo-Abeledo JC; de Vera-González A; González-Delgado A; García-Dopico JA; Jimenez-Sosa A; Rodríguez-Lozano C; González-Gay MA; Ferraz-Amaro I
    Rheumatology (Oxford); 2021 May; 60(5):2296-2306. PubMed ID: 33295631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis.
    Remuzgo-Martínez S; Rueda-Gotor J; Pulito-Cueto V; López-Mejías R; Corrales A; Lera-Gómez L; Pérez-Fernández R; Portilla V; González-Mazón Í; Blanco R; Expósito R; Mata C; Llorca J; Hernández-Hernández V; Rodríguez-Lozano C; Barbarroja N; Ortega-Castro R; Vicente E; Fernández-Carballido C; Martínez-Vidal MP; Castro-Corredor D; Anino-Fernández J; Peiteado D; Plasencia-Rodríguez C; Galíndez-Agirregoikoa E; García-Vivar ML; Vegas-Revenga N; Urionaguena I; Gualillo O; Quevedo-Abeledo JC; Castañeda S; Ferraz-Amaro I; González-Gay MÁ; Genre F
    Front Immunol; 2022; 13():894171. PubMed ID: 35898516
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.